Skip to main content
Premium Trial:

Request an Annual Quote

Pressure BioSciences Delisted from Nasdaq

NEW YORK (GenomeWeb News) – Pressure BioSciences has been delisted by the Nasdaq Stock market after failing to come into compliance with two requirements for continued listing.

The South Easton, Mass.-based sample preparation technologies firm had been told by the Nasdaq Listing Qualifications Panel that it needed to meet two requirements to remain listed: a minimum $1 bid price on its stock for 30 consecutive business days, and $2.5 million in stockholders' equity. It failed to meet either of those requirements by the March 23 deadline set by the stock exchange.

Effective today, Pressure Bio's stock began trading on the OTCQB tier of the OTC Markets. Its stock will continue to trade under the "PBIO" symbol. The firm's shares finished at $.61 in Wednesday trade on the Nasdaq, down 14 percent.

Pressure Bio said in its Form 10-K in February that it has enough cash to last until this month. It filed with the US Securities and Exchange Commission in December to raise $8 million and last month filed an amendment to its filing. The offering of 5 Percent Series E Convertible Preferred Stock has yet to take effect.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.